Q12809 KCNH2_HUMAN
Gene name: KCNH2
Protein name: Potassium voltage-gated channel subfamily H member 2
List of molecules and drugs that target protein Q12809
# | DrugDomain Data | DrugBank Accession | Name | Drug action | Affinity data | InChI Key | SMILES |
---|---|---|---|---|---|---|---|
1 | Q12809_DB00176 | DB00176 | Fluvoxamine | n/a | CJOFXWAVKWHTFT-XSFVSMFZSA-N | COCCCC\C(=N/OCCN)C1=CC=C(C=C1)C(F)(F)F | |
2 | Q12809_DB00199 | DB00199 | Erythromycin | inhibitor | IC50(nM) = 39.0 | ULGZDMOVFRHVEP-RWJQBGPGSA-N | CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O |
3 | Q12809_DB00204 | DB00204 | Dofetilide | inhibitor | Ki(nM) = 6.4 IC50(nM) = 4.1 | IXTMWRCNAAVVAI-UHFFFAOYSA-N | CN(CCOC1=CC=C(NS(C)(=O)=O)C=C1)CCC1=CC=C(NS(C)(=O)=O)C=C1 |
4 | Q12809_DB00252 | DB00252 | Phenytoin | inhibitor | IC50(nM) = 100000.0 | CXOFVDLJLONNDW-UHFFFAOYSA-N | O=C1NC(=O)C(N1)(C1=CC=CC=C1)C1=CC=CC=C1 |
5 | Q12809_DB00276 | DB00276 | Amsacrine | inhibitor | IC50(nM) = 208.93 | XCPGHVQEEXUHNC-UHFFFAOYSA-N | COC1=C(NC2=C3C=CC=CC3=NC3=CC=CC=C23)C=CC(NS(C)(=O)=O)=C1 |
6 | Q12809_DB00280 | DB00280 | Disopyramide | inhibitor | IC50(nM) = 12000.0 | UVTNFZQICZKOEM-UHFFFAOYSA-N | CC(C)N(CCC(C(N)=O)(C1=CC=CC=C1)C1=NC=CC=C1)C(C)C |
7 | Q12809_DB00308 | DB00308 | Ibutilide | inhibitor | IC50(nM) = 10.0 | ALOBUEHUHMBRLE-UHFFFAOYSA-N | CCCCCCCN(CC)CCCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 |
8 | Q12809_DB00342 | DB00342 | Terfenadine | inhibitor | Ki(nM) = 56.0 IC50(nM) = 8.9 | GUGOEEXESWIERI-UHFFFAOYSA-N | CC(C)(C)C1=CC=C(C=C1)C(O)CCCN1CCC(CC1)C(O)(C1=CC=CC=C1)C1=CC=CC=C1 |
9 | Q12809_DB00455 | DB00455 | Loratadine | antagonist | IC50(nM) = 169.82 | JCCNYMKQOSZNPW-UHFFFAOYSA-N | CCOC(=O)N1CCC(CC1)=C1C2=C(CCC3=C1N=CC=C3)C=C(Cl)C=C2 |
10 | Q12809_DB00457 | DB00457 | Prazosin | inhibitor | IC50(nM) = 1584.89 | IENZQIKPVFGBNW-UHFFFAOYSA-N | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1=CC=CO1 |
11 | Q12809_DB00458 | DB00458 | Imipramine | inhibitor | IC50(nM) = 3388.0 | BCGWQEUPMDMJNV-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2CCC2=CC=CC=C12 |
12 | Q12809_DB00472 | DB00472 | Fluoxetine | inhibitor | IC50(nM) = 457.09 | RTHCYVBBDHJXIQ-UHFFFAOYSA-N | CNCCC(OC1=CC=C(C=C1)C(F)(F)F)C1=CC=CC=C1 |
13 | Q12809_DB00477 | DB00477 | Chlorpromazine | inhibitor | IC50(nM) = 1470.0 | ZPEIMTDSQAKGNT-UHFFFAOYSA-N | CN(C)CCCN1C2=CC=CC=C2SC2=C1C=C(Cl)C=C2 |
14 | Q12809_DB00489 | DB00489 | Sotalol | inhibitor | ZBMZVLHSJCTVON-UHFFFAOYSA-N | CC(C)NCC(O)C1=CC=C(NS(C)(=O)=O)C=C1 | |
15 | Q12809_DB00537 | DB00537 | Ciprofloxacin | n/a | Ki(nM) = 100000.0 IC50(nM) = 30000.0 | MYSWGUAQZAJSOK-UHFFFAOYSA-N | OC(=O)C1=CN(C2CC2)C2=CC(N3CCNCC3)=C(F)C=C2C1=O |
16 | Q12809_DB00557 | DB00557 | Hydroxyzine | inhibitor | ZQDWXGKKHFNSQK-UHFFFAOYSA-N | OCCOCCN1CCN(CC1)C(C1=CC=CC=C1)C1=CC=C(Cl)C=C1 | |
17 | Q12809_DB00604 | DB00604 | Cisapride | inhibitor | DCSUBABJRXZOMT-IRLDBZIGSA-N | CO[C@H]1CN(CCCOC2=CC=C(F)C=C2)CC[C@H]1NC(=O)C1=CC(Cl)=C(N)C=C1OC | |
18 | Q12809_DB00637 | DB00637 | Astemizole | inhibitor | Ki(nM) = 2.9 IC50(nM) = 0.9 EC50(nM) = 1.9 | GXDALQBWZGODGZ-UHFFFAOYSA-N | COC1=CC=C(CCN2CCC(CC2)NC2=NC3=CC=CC=C3N2CC2=CC=C(F)C=C2)C=C1 |
19 | Q12809_DB00661 | DB00661 | Verapamil | inhibitor | IC50(nM) = 141.0 | SGTNSNPWRIOYBX-UHFFFAOYSA-N | COC1=C(OC)C=C(CCN(C)CCCC(C#N)(C(C)C)C2=CC(OC)=C(OC)C=C2)C=C1 |
20 | Q12809_DB00675 | DB00675 | Tamoxifen | inhibitor | IC50(nM) = 1584.89 | NKANXQFJJICGDU-QPLCGJKRSA-N | CC\C(=C(/C1=CC=CC=C1)C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC=C1 |
21 | Q12809_DB00679 | DB00679 | Thioridazine | inhibitor | Ki(nM) = 191.0 IC50(nM) = 33.0 | KLBQZWRITKRQQV-UHFFFAOYSA-N | CSC1=CC2=C(SC3=CC=CC=C3N2CCC2CCCCN2C)C=C1 |
22 | Q12809_DB00836 | DB00836 | Loperamide | blocker | IC50(nM) = 33.0 | RDOIQAHITMMDAJ-UHFFFAOYSA-N | CN(C)C(=O)C(CCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)(C1=CC=CC=C1)C1=CC=CC=C1 |
23 | Q12809_DB00908 | DB00908 | Quinidine | inhibitor | IC50(nM) = 324.0 | LOUPRKONTZGTKE-LHHVKLHASA-N | [H][C@@]12CCN(C[C@@H]1C=C)[C@]([H])(C2)[C@@H](O)C1=C2C=C(OC)C=CC2=NC=C1 |
24 | Q12809_DB01026 | DB01026 | Ketoconazole | inhibitor | XMAYWYJOQHXEEK-UHFFFAOYSA-N | CC(=O)N1CCN(CC1)C1=CC=C(OCC2COC(CN3C=CN=C3)(O2)C2=CC=C(Cl)C=C2Cl)C=C1 | |
25 | Q12809_DB01035 | DB01035 | Procainamide | inhibitor | IC50(nM) = 138038.43 | REQCZEXYDRLIBE-UHFFFAOYSA-N | CCN(CC)CCNC(=O)C1=CC=C(N)C=C1 |
26 | Q12809_DB01074 | DB01074 | Perhexiline | n/a | IC50(nM) = 7762.0 | CYXKNKQEMFBLER-UHFFFAOYSA-N | C(C(C1CCCCC1)C1CCCCC1)C1CCCCN1 |
27 | Q12809_DB01100 | DB01100 | Pimozide | inhibitor | Ki(nM) = 18.0 IC50(nM) = 3.02 | YVUQSNJEYSNKRX-UHFFFAOYSA-N | FC1=CC=C(C=C1)C(CCCN1CCC(CC1)N1C(=O)NC2=CC=CC=C12)C1=CC=C(F)C=C1 |
28 | Q12809_DB01136 | DB01136 | Carvedilol | inhibitor | IC50(nM) = 350.0 | OGHNVEJMJSYVRP-UHFFFAOYSA-N | COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=C1C1=CC=CC=C1N2 |
29 | Q12809_DB01142 | DB01142 | Doxepin | inhibitor | ODQWQRRAPPTVAG-UHFFFAOYSA-N | [H]C(CCN(C)C)=C1C2=CC=CC=C2COC2=CC=CC=C12 | |
30 | Q12809_DB01149 | DB01149 | Nefazodone | antagonist | VRBKIVRKKCLPHA-UHFFFAOYSA-N | CCC1=NN(CCCN2CCN(CC2)C2=CC(Cl)=CC=C2)C(=O)N1CCOC1=CC=CC=C1 | |
31 | Q12809_DB01162 | DB01162 | Terazosin | inhibitor | IC50(nM) = 17782.79 | VCKUSRYTPJJLNI-UHFFFAOYSA-N | COC1=C(OC)C=C2C(N)=NC(=NC2=C1)N1CCN(CC1)C(=O)C1CCCO1 |
32 | Q12809_DB01182 | DB01182 | Propafenone | inhibitor | IC50(nM) = 440.0 | JWHAUXFOSRPERK-UHFFFAOYSA-N | CCCNCC(O)COC1=C(C=CC=C1)C(=O)CCC1=CC=CC=C1 |
33 | Q12809_DB01195 | DB01195 | Flecainide | inhibitor | IC50(nM) = 3890.0 | DJBNUMBKLMJRSA-UHFFFAOYSA-N | FC(F)(F)COC1=CC(C(=O)NCC2CCCCN2)=C(OCC(F)(F)F)C=C1 |
34 | Q12809_DB01211 | DB01211 | Clarithromycin | n/a | IC50(nM) = 33113.0 | AGOYDEPGAOXOCK-KCBOHYOISA-N | [H][C@@]1(C[C@@](C)(OC)[C@@H](O)[C@H](C)O1)O[C@H]1[C@H](C)[C@@H](O[C@]2([H])O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@](C)(O)[C@@H](CC)OC(=O)[C@@H]1C)OC |
35 | Q12809_DB01218 | DB01218 | Halofantrine | inhibitor | Ki(nM) = 7500.0 IC50(nM) = 40.0 | FOHHNHSLJDZUGQ-UHFFFAOYSA-N | CCCCN(CCCC)CCC(O)C1=C2C=CC(=CC2=C2C=C(Cl)C=C(Cl)C2=C1)C(F)(F)F |
36 | Q12809_DB01244 | DB01244 | Bepridil | inhibitor | Ki(nM) = 184.0 IC50(nM) = 22.91 | UIEATEWHFDRYRU-UHFFFAOYSA-N | CC(C)COCC(CN(CC1=CC=CC=C1)C1=CC=CC=C1)N1CCCC1 |
37 | Q12809_DB04855 | DB04855 | Dronedarone | inhibitor | IC50(nM) = 316.23 | ZQTNQVWKHCQYLQ-UHFFFAOYSA-N | CCCCN(CCCC)CCCOC1=CC=C(C=C1)C(=O)C1=C(CCCC)OC2=C1C=C(NS(C)(=O)=O)C=C2 |
38 | Q12809_DB04957 | DB04957 | Azimilide | n/a | MREBEPTUUMTTIA-UHFFFAOYSA-N | CN1CCN(CCCCN2C(=O)CN(N=CC3=CC=C(O3)C3=CC=C(Cl)C=C3)C2=O)CC1 | |
39 | Q12809_DB06144 | DB06144 | Sertindole | inhibitor | Ki(nM) = 3.0 IC50(nM) = 2.7 | GZKLJWGUPQBVJQ-UHFFFAOYSA-N | FC1=CC=C(C=C1)N1C=C(C2CCN(CCN3CCNC3=O)CC2)C2=C1C=CC(Cl)=C2 |
40 | Q12809_DB06217 | DB06217 | Vernakalant | blocker | VBHQKCBVWWUUKN-KZNAEPCWSA-N | COC1=C(OC)C=C(CCO[C@@H]2CCCC[C@H]2N2CC[C@@H](O)C2)C=C1 | |
41 | Q12809_DB06457 | DB06457 | Tecastemizole | n/a | SFOVDSLXFUGAIV-UHFFFAOYSA-N | FC1=CC=C(CN2C(NC3CCNCC3)=NC3=CC=CC=C23)C=C1 | |
42 | Q12809_DB11090 | DB11090 | Potassium nitrate | agonist | FGIUAXJPYTZDNR-UHFFFAOYSA-N | [K+].[O-][N+]([O-])=O | |
43 | Q12809_DB11186 | DB11186 | Pentoxyverine | inhibitor | CFJMRBQWBDQYMK-UHFFFAOYSA-N | CCN(CC)CCOCCOC(=O)C1(CCCC1)C1=CC=CC=C1 | |
44 | Q12809_DB11386 | DB11386 | Chlorobutanol | n/a | OSASVXMJTNOKOY-UHFFFAOYSA-N | CC(C)(O)C(Cl)(Cl)Cl | |
45 | Q12809_DB11633 | DB11633 | Isavuconazole | inhibitor | DDFOUSQFMYRUQK-RCDICMHDSA-N | C[C@@H](C1=NC(=CS1)C1=CC=C(C=C1)C#N)[C@](O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1 | |
46 | Q12809_DB11642 | DB11642 | Pitolisant | blocker | NNACHAUCXXVJSP-UHFFFAOYSA-N | ClC1=CC=C(CCCOCCCN2CCCCC2)C=C1 |